The Enhanced International Prognostic Index for Diffuse Large B‐cell Lymphoma | Semantic Scholar
CT-Based Versus FDG-PET/CT–Based NCCN International Prognostic Index Risk Stratification in DLBCL in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 2 (2015)
Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma
xmlinkhub
Immunohistochemical double hit score enhances NCCN–IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma - Prochazka - 2018 - British Journal of Haematology -
Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Table 4 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Improving the Prognostic Index for Diffuse Large B-Cell Lymphoma
KoreaMed Synapse
We applied the model of (A) NCCN-IPI in our study. Compared with (B)... | Download Scientific Diagram
Table 1 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to Management?
Age cutoffs for the conventional IPI, NCCN-IPI, and GELTAMO-IPI | Download Scientific Diagram
EHA Library - The official digital education library of European Hematology Association (EHA)
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. - Abstract - Europe PMC
The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study | Cancer Cell International | Full Text
Survival analysis according to NCCN-IPI (low NCCN-IPI score < 5 and... | Download Scientific Diagram
Improving the Prognostic Index for Diffuse Large B-Cell Lymphoma
Frontiers | Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study
